Carrie Krehlik

Carrie Krehlik is a declared insider of Global Blood Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 4 filings, for trades running from 1 September 2022 to 5 October 2022.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 6 October 2022, the filings show a transaction in Global Blood Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.